SCHEMBL30474693

SCHEMBL30474693

CC(C)(C)OC(=O)Nc1ccc(-c2cccnn2)cc1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 7/20 0.46
CYP17A1 P05093 4/20 0.43
BRD9 Q9H8M2 1/20 0.42
HDAC3 O15379 2/20 0.39
IRAK4 Q9NWZ3 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
NCOR2 Q9Y618 1/20 0.39
METAP1 P53582 1/20 0.39
MAP4K4 O95819 1/20 0.39
HDAC4 P56524 1/20 0.38
PIK3CD O00329 1/20 0.37
ABL1 P00519 1/20 0.37
EGFR P00533 1/20 0.37
KDR P35968 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CG P48736 1/20 0.37
BACE1 P56817 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25216637 1.00 AAK1 (0.46) AAK1CYP17A1BRD9HDAC3IRAK4
SCHEMBL5869249 0.85 AAK1 (0.48) AAK1CYP17A1BRD9HDAC3IRAK4
SCHEMBL31109020 0.82 ABCB1 (0.42) CYP17A1BRD9
SCHEMBL25214659 0.82 ABCB1 (0.42) CYP17A1BRD9
SCHEMBL25214140 0.81 AAK1 (0.51) AAK1CYP17A1BRD9HDAC1METAP1
SCHEMBL2133767 0.80 AAK1 (0.52) AAK1CYP17A1HDAC3HDAC1HDAC2
SCHEMBL29530597 0.80 AAK1 (0.52) AAK1CYP17A1HDAC3HDAC1HDAC2
SCHEMBL30058636 0.79 AAK1 (0.68) AAK1CYP17A1HDAC3HDAC1HDAC2
SCHEMBL5868960 0.79 AAK1 (0.68) AAK1CYP17A1HDAC3HDAC1HDAC2
SCHEMBL30118372 0.79 AAK1 (0.48) AAK1CYP17A1HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4441033-A1 NOVEL HDAC INHIBITORS AND THERAPEUTIC USE THEREOF Tango Therapeutics, Inc. (US) 2024-10-09 EP disclosed
WO-2023102162-A1 TGONOVEL HDAC INHIBITORS AND THERAPEUTIC USE THEREOF TANGO THERAPEUTICS, INC. (US) 2023-06-08 WO disclosed